LIPOSOMAL IRINOTECAN

Clinical trials for LIPOSOMAL IRINOTECAN explained in plain language.

Never miss a new study

Get alerted when new LIPOSOMAL IRINOTECAN trials appear

Sign up with your email to follow new studies for LIPOSOMAL IRINOTECAN, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.

Our safety recommendation!

By submitting, you agree to our Terms of use

Not yet recruiting 1

New drug combo aims to improve second-line treatment for advanced colorectal cancer

Disease control Not yet recruiting

This study tests whether a liposomal (encapsulated) form of irinotecan combined with other drugs works better than standard irinotecan for people with metastatic colorectal cancer that has progressed after first-line treatment. About 408 adults aged 18-75 will be randomly assigne…

Matched conditions: LIPOSOMAL IRINOTECAN

Phase: PHASE2, PHASE3 • Sponsor: Hebei Medical University Fourth Hospital • Aim: Disease control

Last updated May 17, 2026 04:14 UTC

LIPOSOMAL IRINOTECAN

Get alerted when new LIPOSOMAL IRINOTECAN trials appear

New drug combo aims to improve second-line treatment for advanced colorectal cancer